[1]余小夏,何仁健,赵露婷,等.富血小板血浆关节腔注射治疗慢性膝关节骨性关节炎对患者疼痛情况及血清基质金属蛋白酶-3、软骨寡聚基质蛋白水平的影响研究[J].陕西医学杂志,2024,(7):918-921,953.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.011]
 YU Xiaoxia,HE Renjian,ZHAO Luting,et al.Effect of intra-articular injection of platelet-rich plasma on pain and serum MMP-3 and COMP in patients with chronic knee osteoarthritis[J].,2024,(7):918-921,953.[doi:DOI:10.3969/j.issn.1000-7377.2024.07.011]
点击复制

富血小板血浆关节腔注射治疗慢性膝关节骨性关节炎对患者疼痛情况及血清基质金属蛋白酶-3、软骨寡聚基质蛋白水平的影响研究
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年7期
页码:
918-921,953
栏目:
临床研究
出版日期:
2024-07-05

文章信息/Info

Title:
Effect of intra-articular injection of platelet-rich plasma on pain and serum MMP-3 and COMP in patients with chronic knee osteoarthritis
作者:
余小夏1何仁健2赵露婷1杨 凌1
(1.四川大学华西医院资阳医院 资阳市中心医院康复科,四川 资阳 641300; 2.自贡市第一人民医院骨科,四川 自贡 643000)
Author(s):
YU XiaoxiaHE RenjianZHAO LutingYANG Ling
(Department of Rehabilitation,Ziyang Hospital,West China Hospital,Sichuan University,Ziyang 641300,China)
关键词:
富血小板血浆 慢性膝关节骨性关节炎 基质金属蛋白酶-3 软骨寡聚基质蛋白 疼痛视觉模拟评分 透明质酸
Keywords:
Platelet-rich plasma Chronic knee osteoarthritis Matrix metalloproteinase-3 Cartilage oligomeric matrix protein Visual Analogue Scale Score Hyaluronic acid
分类号:
R 684.3
DOI:
DOI:10.3969/j.issn.1000-7377.2024.07.011
文献标志码:
A
摘要:
目的:探究富血小板血浆(PRP)关节腔注射治疗慢性膝关节骨性关节炎(KOA)对患者疼痛情况及血清基质金属蛋白酶-3(MMP-3)、软骨寡聚基质蛋白(COMP)水平的影响。方法:选取86例慢性KOA患者,按随机信封法分为透明质酸(HA)组和PRP组,每组43例。HA组予以关节腔注射HA治疗,每次2 ml,PRP组以相同操作注射PRP,每次3.5 ml,两组均每周1次,连续治疗3周。比较两组治疗前后疼痛评分、症状严重程度、膝关节评分、血清炎症因子水平及不良反应发生情况。结果:治疗后3、6个月PRP组疼痛评分低于HA组(均P<0.05); 治疗后3、6个月PRP组疼痛不适、步行能力及日常生活受累程度改善情况均优于HA组(均P<0.05); 治疗后3、6个月PRP组膝关节评分显著低于HA组(均P<0.05); 治疗后3个月PRP组血清中MMP-3及COMP水平低于HA组(均P<0.05); 两组不良反应发生情况比较差异无统计学意义(P>0.05)。结论:注射PRP对慢性KOA的远期疗效明显,可减轻其关节疼痛,改善关节功能,减轻膝关节炎症,安全性高。
Abstract:
Objective:To explore the effect of intra-articular injection of platelet-rich plasma(PRP)on pain and serum levels of matrix metalloproteinase-3(MMP-3)and cartilage oligomeric matrix protein(COMP)in patients with chronic knee osteoarthritis(KOA).Methods:A total of 86 patients with chronic KOA were selected and divided into hyaluronic acid(HA)group and PRP group by the random envelope method,with 43 cases in each group.The HA group was treated with intra-articular injection of 2 ml of HA every time,and the PRP group was treated with 3.5 ml of PRP every time in the same injection method,and both groups were injected once a week for 3 consecutive weeks.Pain score,symptom severity,knee joint score,serum inflammatory factors levels and occurrence of complications were compared between the two groups before and after treatment.Results:The pain scores in PRP group were lower than those in HA group at 3 and 6 months after treatment(all P<0.05).At 3 and 6 months after treatment,the improvement of pain and discomfort,walking ability and involvement degree of daily life in the PRP group were better than those in the HA group(all P<0.05).The knee joint scores at 3 and 6 months after treatment in PRP group were significantly lower than those in HA group(all P<0.05).The serum levels of MMP-3 and COMP in PRP group were lower than those in HA group at 3 months after treatment(all P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:PRP injection has obvious long-term efficacy on chronic KOA,and it can relieve the joint pain,improve the joint function,and reduce knee joint inflammation,with high safety.

参考文献/References:

[1] 丁小芬,周友龙,田明月,等.Wnt/β-catenin信号通路与膝关节骨性关节炎软骨代谢[J].中国老年学杂志,2022,42(23):5917-5921.
[2] 刘兆丰,王大斌,李军.藤黄健骨片联合常规西药对老年膝关节骨性关节炎(肝肾不足、筋脉瘀滞证)的作用[J].中国老年学杂志,2022,42(6):1424-1427.
[3] 贾芝和,何敏,胡华平,等.膝关节骨性关节炎老年患者人工关节置换术后切口感染的危险因素[J].中国老年学杂志,2023,43(11):2642-2644.
[4] 邱皓,陈诗谋,翁政,等.富血小板血浆干预膝关节骨性关节炎模型兔关节软骨和滑膜的改变[J].中国组织工程研究,2020,24(14):2205-2210.
[5] ABD E R M,WANG X,MIUSI S,et al.Injectable-platelet rich fibrin using the low speed centrifugation concept improves cartilage regeneration when compared to platelet-rich plasma[J].Platelets,2019,30(2):213-221.
[6] 中华医学会骨科学分会.骨关节炎诊治指南(2007年版)[J].中华骨科杂志,2007,27(10):793-796.
[7] 王赵洋,高文飞,邵一鸣,等.3.0T MRI T2 mapping序列对富血小板血浆治疗早、中期膝骨关节炎的临床效果评价[J].中华外科杂志,2023,61(2):138-144.
[8] 陶金刚.富血小板血浆联合塞来昔布治疗膝关节骨性关节炎患者[J].临床与病理杂志,2021,41(4):758-763.
[9] 张辉,李鸿,李叶天,等.后交叉韧带保留型和后稳定型全膝关节假体置换后早期关节遗忘度的对比[J].中国组织工程研究,2020,24(30):4802-4806.
[10] 李龙建,邱永荣,林子丰,等.塞来昔布联合盐酸氨基葡萄糖促进老年膝关节骨性关节炎患者功能恢复和降低炎症因子水平[J].中国老年学杂志,2023,43(17):4191-4193.
[11] 王晓川,孙运中,马建云,等.膝关节腔脉冲射频治疗膝骨性关节炎的临床观察[J].中国疼痛医学杂志,2021,27(10):785-788.
[12] 黄双霜,向小娜,余曦,等.富血小板血浆来源外泌体治疗膝骨关节炎的机制与作用[J].中国组织工程研究,2023,27(15):2420-2426.
[13] 杜薇,丁宇,崔洪鹏,等.椎间孔镜联合富血小板血浆治疗椎间盘源性腰痛[J].中国矫形外科杂志,2023,31(10):887-891.
[14] 张紫钰,王一茗,李涵,等.富血小板血浆满足不同类型关节软骨损伤的治疗需求[J].中国组织工程研究,2023,27(17):2772-2779.
[15] 房昕,郭金铭,刘品端.不同浓度富血小板血浆修复兔膝骨关节炎软骨缺损的比较[J].中国组织工程研究,2021,25(35):5588-5593.
[16] 高献忠,管华,陆伟萍,等.膝关节腔注射富血小板血浆对老年患者膝关节骨性关节炎疼痛的影响[J].临床麻醉学杂志,2020,36(12):1157-1160.
[17] 张虹,程秀宇,季有波.中西医结合治疗中老年膝关节骨性关节炎的临床疗效[J].中国老年学杂志,2019,39(18):4481-4485.
[18] SUNDMAN E A,COLE B J,KARAS V,et al.The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis[J].Am J Sports Med,2014,42(1):35-41.
[19] SAITO M,TAKAHASHI K A,ARAI Y,et al.Intraarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee[J].Clin Exp Rheumatol,2009,27(2):201-207.
[20] MEHANA E E,KHAFAGA A F,EL-BLEHI S S.The role of matrix metalloproteinases in osteoarthritis pathogenesis:An updated review[J].Life Sci,2019,234:116786.
[21] 金炼驰,赖永洁.软骨寡聚基质蛋白与疾病关系的研究进展[J].天津医药,2021,49(3):330-336.
[22] 陈勇,吴培培,朱敏敏,等.关节腔内注射PRP对膝骨性关节炎化脓性感染疼痛介质与NLRP3/IL-1β通路的影响[J].中华医院感染学杂志,2022,32(15):2338-2342.
[23] 中国医疗保健国际交流促进会骨科分会.富血小板血浆在骨关节外科临床应用专家共识(2018年版)[J].中华关节外科杂志:电子版,2018,12(5):596-600.
[24] 任昊喆, 牟婧, 赵子璇, 等. 细胞外信号调节蛋白激酶在颞下颌关节骨关节炎髁突软骨退变中的作用[J].空军军医大学学报,2023,44(6):490-495.
[25] 郑赛磊,冷子宽,尚春风,等.富血小板血浆与玻璃酸钠治疗膝骨关节炎的疗效对比[J].中华实验外科杂志,2023,40(1):165-168.
[26] 赵露婷,方其林,唐海燕,等.自体、同种异体纯化富血小板血浆治疗兔膝骨关节炎的差异[J].中国组织工程研究,2021,25(26):4123-4129.

相似文献/References:

[1]梁朝鑫,周安远,吴立蔚,等.富血小板血浆在骨科疾病治疗中的研究进展[J].陕西医学杂志,2021,50(12):1605.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.035]
 LIANG Chaoxin,ZHOU Anyuan,WU Liwei,et al.Research progress of platelet-rich plasma in treatment of orthopedic diseases[J].,2021,50(7):1605.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.035]

备注/Memo

备注/Memo:
基金项目:四川省青年创新科研计划项目(Q20072); 四川省医学科技创新研究会项目(YCH-ZZ2023-009)
更新日期/Last Update: 2024-07-04